Share
When you hear the words Alzheimer's disease, what do you think of? The truth is, the picture most of us have of the disease is incomplete. Alzheimer's disease doesn't start when someone starts to lose their memory. It actually starts years – sometimes decades – earlier. The Rethinking Alzheimer's Disease Podcast is an engaging, narrative-style podcast miniseries for those curious or motivated to learn about Alzheimer’s disease. Perhaps you have a family member with Alzheimer’s disease, or ca ...
…
continue reading
Manage episode 523568196 series 2521132
Content provided by The College of Optometrists. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The College of Optometrists or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
College Clinical Advisers Denise Voon MCOptom, Dr Paramdeep Bilkhu MCOptom, and Daniel Hardiman-McCartney FCOptom MBE discuss the recent news from the Medicines and Healthcare products Regulatory Agency (MHRA) approving the first low-dose atropine treatment for myopia in the UK.
They talk about what the news means for optometrists and answer questions from College members.
Further information
107 episodes
))
